Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayer Fishman

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational studyPamela Münster, Douglas Marchion, Elona Bicaku, et al.
Urology Practice|August 18, 2023
Sociodemographic and Provider Based Disparities in the Management of Stage I Testicular CancerGautum Agarwal, Pranav Sharma, Oscar Valderrama, et al.
Urologic Oncology|November 8, 2015
Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbiditiesScott M Haake, Samira A Brooks, Eric Welsh, et al.
Journal of Psychosomatic Research|January 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patientsJulie M Cessna, Heather S L Jim, Steven K Sutton, et al.
Cancer|October 13, 2006
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumorsDavid P Ryan, Leonard J Appleman, Thomas Lynch, et al.
Nature Immunology|January 29, 2013
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancerJe-In Youn, Vinit Kumar, Michelle Collazo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Clinical Genitourinary Cancer|June 4, 2018
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional ExperienceCharles C Peyton, Mounsif Azizi, Juan Chipollini, et al.
Psycho-Oncology|June 21, 2012
Effects of self-directed stress management training and home-based exercise on quality of life in cancer patients receiving chemotherapy: a randomized controlled trialPaul B Jacobsen, Kristin M Phillips, Heather S L Jim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxelGerald J Fetterly, Thaddeus H Grasela, Jeffrey W Sherman, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2007
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational studyPamela Münster, Douglas Marchion, Elona Bicaku, et al.
Urology Practice|August 18, 2023
Sociodemographic and Provider Based Disparities in the Management of Stage I Testicular CancerGautum Agarwal, Pranav Sharma, Oscar Valderrama, et al.
Urologic Oncology|November 8, 2015
Patients with ClearCode34-identified molecular subtypes of clear cell renal cell carcinoma represent unique populations with distinct comorbiditiesScott M Haake, Samira A Brooks, Eric Welsh, et al.
Journal of Psychosomatic Research|January 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patientsJulie M Cessna, Heather S L Jim, Steven K Sutton, et al.
Cancer|October 13, 2006
Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumorsDavid P Ryan, Leonard J Appleman, Thomas Lynch, et al.
Nature Immunology|January 29, 2013
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancerJe-In Youn, Vinit Kumar, Michelle Collazo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancerDavid S Hong, Razelle Kurzrock, Yun Oh, et al.
Clinical Genitourinary Cancer|June 4, 2018
Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional ExperienceCharles C Peyton, Mounsif Azizi, Juan Chipollini, et al.
Psycho-Oncology|June 21, 2012
Effects of self-directed stress management training and home-based exercise on quality of life in cancer patients receiving chemotherapy: a randomized controlled trialPaul B Jacobsen, Kristin M Phillips, Heather S L Jim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2008
Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxelGerald J Fetterly, Thaddeus H Grasela, Jeffrey W Sherman, et al.
Pageof 7